Bundamedik Tbk PT
IDX:BMHS
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
240
378
|
Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one BMHS stock under the Base Case scenario is 358.22 IDR. Compared to the current market price of 264 IDR, Bundamedik Tbk PT is Undervalued by 26%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Bundamedik Tbk PT
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for BMHS cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Bundamedik Tbk PT
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Bundamedik Tbk PT
Balance Sheet Decomposition
Bundamedik Tbk PT
Current Assets | 1.4T |
Cash & Short-Term Investments | 1.2T |
Receivables | 149.8B |
Other Current Assets | 119.6B |
Non-Current Assets | 2.3T |
Long-Term Investments | 83.2B |
PP&E | 2.1T |
Intangibles | 94.8B |
Other Non-Current Assets | 92.8B |
Current Liabilities | 808.5B |
Accounts Payable | 45.4B |
Accrued Liabilities | 27.5B |
Short-Term Debt | 701.4B |
Other Current Liabilities | 34.1B |
Non-Current Liabilities | 1.4T |
Long-Term Debt | 784.1B |
Other Non-Current Liabilities | 584.6B |
Earnings Waterfall
Bundamedik Tbk PT
Revenue
|
1.5T
IDR
|
Cost of Revenue
|
-817.5B
IDR
|
Gross Profit
|
728.8B
IDR
|
Operating Expenses
|
-624.9B
IDR
|
Operating Income
|
104B
IDR
|
Other Expenses
|
-90.9B
IDR
|
Net Income
|
13B
IDR
|
Free Cash Flow Analysis
Bundamedik Tbk PT
IDR | |
Free Cash Flow | IDR |
BMHS Profitability Score
Profitability Due Diligence
Bundamedik Tbk PT's profitability score is 44/100. The higher the profitability score, the more profitable the company is.
Score
Bundamedik Tbk PT's profitability score is 44/100. The higher the profitability score, the more profitable the company is.
BMHS Solvency Score
Solvency Due Diligence
Bundamedik Tbk PT's solvency score is 38/100. The higher the solvency score, the more solvent the company is.
Score
Bundamedik Tbk PT's solvency score is 38/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BMHS Price Targets Summary
Bundamedik Tbk PT
According to Wall Street analysts, the average 1-year price target for BMHS is 295.8 IDR with a low forecast of 292.9 IDR and a high forecast of 304.5 IDR.
Dividends
Current shareholder yield for BMHS is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
PT Bundamedik Tbk is a holding company, with engages in the provision of healthcare and medical technology services. The company is headquartered in Jakarta Pusat, Dki Jakarta and currently employs 1,285 full-time employees. The company went IPO on 2021-07-06. The firm is engaged in private hospital activities, private polyclinic activities, and other hospital activities. The Company’s also offers other hospital activities, such as healthcare services activities performed by paramedics and health support service activities. The firm operates two general clinics in Jakarta and Bekasi that offer services, such as obstetrics and gynecology specialist poly, child specialist poly, skin and aesthetic poly, dental and oral poly, general poly, medical check-ups, internal medicine poly, poly nutrition, and pharmacy. The company offers a range of services, such as mother and child services, outpatient services, inpatient services, in vitro fertilization (IVF) services, and clinical laboratory services. The firm operates approximately two maternal and child hospitals, three general hospitals, 10 IVF clinics, 14 laboratories and various other supporting business activities.
Contact
IPO
Employees
Officers
The intrinsic value of one BMHS stock under the Base Case scenario is 358.22 IDR.
Compared to the current market price of 264 IDR, Bundamedik Tbk PT is Undervalued by 26%.